Mitochondrial and cellular-energy dysfunction patterns

What records in this area tend to contain

These are descriptions of records, not diagnostic criteria. Recognising several of them does not mean you have a condition, and none of them is being asserted about you.

• Exertional intolerance with a delayed, disproportionate payback period
• Organic acid results read as Krebs-cycle or fatty-acid-oxidation bottlenecks
• Cofactor and nutrient findings — B vitamins, carnitine, CoQ10, iron studies — of uncertain significance
• Lactate, pyruvate, or amino acid findings collected without a clinical question attached
• Prior supplement trials aimed at energy metabolism, with unclear or unrecorded effect
• Overlap with post-infectious, autonomic, or thyroid findings that complicate attribution

The analytical work on a case like this

• The exertion–recovery chronology in enough detail to characterise the pattern
• Every metabolic and organic-acid result, with an explicit note on what each assay can and cannot show
• Iron, thyroid, and haematological contributors that mimic an energy-supply problem
• Redox, cofactor availability, and electron-transport hypotheses, graded by evidence strength
• Medication and exposure history relevant to mitochondrial function
• Whether prior interventions produced changes consistent with the leading hypothesis

What the work is trying to answer

These are the questions the reconstruction is built around. They are questions, not promises — some records answer them clearly and some do not, and the written synthesis says which.

• Do the available results support a cellular-energy reading, or only permit it?
• Is deconditioning, iron status, thyroid function, or autonomic limitation a better explanation for the ceiling?
• Which nutrient or cofactor findings are actionable questions for a clinician, and which are noise?
• What would distinguish a supply-side energy problem from a demand-side autonomic one?

What would argue against the leading reading

Every synthesis states the alternatives it could not exclude. For this area, the most important ones are:

• Autonomic limitation, where circulation rather than mitochondria caps exertion
• Iron deficiency, thyroid dysfunction, sleep-disordered breathing, or anaemia
• Deconditioning and activity-avoidance cycles, which can coexist rather than compete
• Immune or inflammatory drivers with metabolic findings as a downstream signature
• Assay limitations: many commercial mitochondrial panels lack validation for individual inference

Related reading on this site

• Mitochondrial dysfunction
• Colonocyte bioenergetics
• The Host Capacity Model

• Recurrent SIBO, dysbiosis and motility

  For digestive cases that relapse after each round of treatment, where the question has become why the environment keeps reselecting the same pattern.

• Bile acid and enterohepatic patterns

  For cases where fat handling, post-cholecystectomy change, bile-acid diarrhoea questions, or sequestrant responses sit at the centre of the record.

All Areas of Analysis →